Johnson Investment Counsel Inc Johnson & Johnson Transaction History

Johnson Investment Counsel Inc

$10.1 Billion
Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 194,519 shares of JNJ stock, worth $30.2 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

194,519

Previous 196,028 0.77%

Holding current value

$30.2 Million

Previous $28.7 Million 10.02%

% of portfolio

0.31%

Previous 0.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $219,529 - $252,576	-1,509 Reduced 0.77%	194,519 $31.5 Million
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $503,308 - $550,021	-3,486 Reduced 1.75%	196,028 $28.7 Million
Q1 2024 May 09, 2024	SELL	$155.22 - $162.74 $186,264 - $195,288	-1,200 Reduced 0.6%	199,514 $31.6 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $4.15 Million - $4.53 Million	-28,490 Reduced 12.43%	200,714 $31.5 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $416,164 - $466,210	2,672 Added 1.18%	229,204 $35.7 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $466,754 - $502,316	3,024 Added 1.35%	226,532 $37.5 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $44,559 - $53,176	295 Added 0.13%	223,508 $34.6 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $674,281 - $756,736	4,209 Added 1.92%	223,213 $39.4 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $375,253 - $417,563	2,326 Added 1.07%	219,004 $35.8 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $705,893 - $780,683	4,197 Added 1.98%	216,678 $38.5 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $576,420 - $654,605	-3,645 Reduced 1.69%	212,481 $37.7 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $88,256 - $97,923	-566 Reduced 0.26%	216,126 $37 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $2.87 Million - $3.19 Million	17,762 Added 8.93%	216,692 $35 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $680,979 - $730,468	-4,270 Reduced 2.1%	198,930 $32.8 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $311,344 - $346,756	2,034 Added 1.01%	203,200 $33.4 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $379,520 - $435,627	-2,768 Reduced 1.36%	201,166 $31.7 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $244,120 - $267,510	-1,739 Reduced 0.85%	203,934 $30.4 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $502,745 - $606,955	-3,903 Reduced 1.86%	205,673 $28.9 Million
Q1 2020 May 20, 2020	SELL	$111.14 - $153.99 $1.03 Million - $1.43 Million	-9,291 Reduced 4.25%	209,576 $27.5 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $1.16 Million - $1.34 Million	-9,131 Reduced 4.0%	218,867 $31.9 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $156,529 - $175,258	-1,233 Reduced 0.54%	227,998 $29.5 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $177,839 - $195,589	-1,356 Reduced 0.59%	229,231 $31.9 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $167,333 - $186,060	-1,331 Reduced 0.57%	230,587 $32.2 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $180,697 - $217,472	1,471 Added 0.64%	231,918 $29.9 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $30,516 - $35,862	251 Added 0.11%	230,447 $31.8 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $701,594 - $774,221	5,876 Added 2.62%	230,196 $27.9 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $603,732 - $714,923	-4,826 Reduced 2.11%	224,320 $28.7 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $229,766 - $251,478	1,751 Added 0.77%	229,146 $32 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $29.4 Million - $30.8 Million	227,395	227,395 $29.6 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Johnson & Johnson Transaction History